Search Tag: Gilead

Grand Plans for Potential COVID-19 Vaccine Production

2020 08 Jun

UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners.   You might also like: EU Supports Clinical Trials During COVID-19   The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed... Read more

Potential COVID-19 Treatments: Some In, Some Out

2020 27 May

The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold.   You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration... Read more